166 related articles for article (PubMed ID: 38229158)
1. Unclassifiable CNS tumors in DNA methylation-based classification: clinical challenges and prognostic impact.
Drexler R; Brembach F; Sauvigny J; Ricklefs FL; Eckhardt A; Bode H; Gempt J; Lamszus K; Westphal M; Schüller U; Mohme M
Acta Neuropathol Commun; 2024 Jan; 12(1):9. PubMed ID: 38229158
[TBL] [Abstract][Full Text] [Related]
2. Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics.
Wu Z; Abdullaev Z; Pratt D; Chung HJ; Skarshaug S; Zgonc V; Perry C; Pack S; Saidkhodjaeva L; Nagaraj S; Tyagi M; Gangalapudi V; Valdez K; Turakulov R; Xi L; Raffeld M; Papanicolau-Sengos A; O'Donnell K; Newford M; Gilbert MR; Sahm F; Suwala AK; von Deimling A; Mamatjan Y; Karimi S; Nassiri F; Zadeh G; Ruppin E; Quezado M; Aldape K
Neuro Oncol; 2022 Apr; 24(4):571-581. PubMed ID: 34555175
[TBL] [Abstract][Full Text] [Related]
3. The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care.
Karimi S; Zuccato JA; Mamatjan Y; Mansouri S; Suppiah S; Nassiri F; Diamandis P; Munoz DG; Aldape KD; Zadeh G
Clin Epigenetics; 2019 Dec; 11(1):185. PubMed ID: 31806041
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation profiling improves routine diagnosis of paediatric central nervous system tumours: A prospective population-based study.
Schepke E; Löfgren M; Pietsch T; Olsson Bontell T; Kling T; Wenger A; Ferreyra Vega S; Danielsson A; Dosa S; Holm S; Öberg A; Nyman P; Eliasson-Hofvander M; Sandström PE; Pfister SM; Lannering B; Sabel M; Carén H
Neuropathol Appl Neurobiol; 2022 Oct; 48(6):e12838. PubMed ID: 35892159
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study.
von Hoff K; Haberler C; Schmitt-Hoffner F; Schepke E; de Rojas T; Jacobs S; Zapotocky M; Sumerauer D; Perek-Polnik M; Dufour C; van Vuurden D; Slavc I; Gojo J; Pickles JC; Gerber NU; Massimino M; Gil-da-Costa MJ; Garami M; Kumirova E; Sehested A; Scheie D; Cruz O; Moreno L; Cho J; Zeller B; Bovenschen N; Grotzer M; Alderete D; Snuderl M; Zheludkova O; Golanov A; Okonechnikov K; Mynarek M; Juhnke BO; Rutkowski S; Schüller U; Pizer B; von Zezschwitz B; Kwiecien R; Wechsung M; Konietschke F; Hwang EI; Sturm D; Pfister SM; von Deimling A; Rushing EJ; Ryzhova M; Hauser P; Łastowska M; Wesseling P; Giangaspero F; Hawkins C; Figarella-Branger D; Eberhart C; Burger P; Gessi M; Korshunov A; Jacques TS; Capper D; Pietsch T; Kool M
Neuro Oncol; 2021 Sep; 23(9):1597-1611. PubMed ID: 34077956
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation-based profiling of bone and soft tissue tumours: a validation study of the 'DKFZ Sarcoma Classifier'.
Lyskjaer I; De Noon S; Tirabosco R; Rocha AM; Lindsay D; Amary F; Ye H; Schrimpf D; Stichel D; Sill M; Koelsche C; Pillay N; Von Deimling A; Beck S; Flanagan AM
J Pathol Clin Res; 2021 Jul; 7(4):350-360. PubMed ID: 33949149
[TBL] [Abstract][Full Text] [Related]
7. Validation of Whole Genome Methylation Profiling Classifier for Central Nervous System Tumors.
Santana-Santos L; Kam KL; Dittmann D; De Vito S; McCord M; Jamshidi P; Fowler H; Wang X; Aalsburg AM; Brat DJ; Horbinski C; Jennings LJ
J Mol Diagn; 2022 Aug; 24(8):924-934. PubMed ID: 35605901
[TBL] [Abstract][Full Text] [Related]
8. Decoding the DNA methylome of central nervous system tumors: An emerging modality for integrated diagnosis.
Satomi K; Ichimura K; Shibahara J
Pathol Int; 2024 Feb; 74(2):51-67. PubMed ID: 38224248
[TBL] [Abstract][Full Text] [Related]
9. Utility of genome-wide DNA methylation profiling for pediatric-type diffuse gliomas.
Otani Y; Satomi K; Suruga Y; Ishida J; Fujii K; Ichimura K; Date I
Brain Tumor Pathol; 2023 Apr; 40(2):56-65. PubMed ID: 37004583
[TBL] [Abstract][Full Text] [Related]
10. Brain tumour diagnostics using a DNA methylation-based classifier as a diagnostic support tool.
Priesterbach-Ackley LP; Boldt HB; Petersen JK; Bervoets N; Scheie D; Ulhøi BP; Gardberg M; Brännström T; Torp SH; Aronica E; Küsters B; den Dunnen WFA; de Vos FYFL; Wesseling P; de Leng WWJ; Kristensen BW
Neuropathol Appl Neurobiol; 2020 Aug; 46(5):478-492. PubMed ID: 32072658
[TBL] [Abstract][Full Text] [Related]
11. The case for DNA methylation based molecular profiling to improve diagnostic accuracy for central nervous system embryonal tumors (not otherwise specified) in adults.
Halliday GC; Junckerstorff RC; Bentel JM; Miles A; Jones DTW; Hovestadt V; Capper D; Endersby R; Cole CH; van Hagen T; Gottardo NG
J Clin Neurosci; 2018 Jan; 47():163-167. PubMed ID: 28993028
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation provides diagnostic value for meningioma recurrence in clinical practice.
Shen E; Leclair NK; Herlth K; Soucy M; Renzette N; Zhuo X; Kelly K; Omerza G; Onyiuke H; McNeill I; Wolansky L; Becker K; Li L; Wu Q; Bulsara KR
Acta Neurochir (Wien); 2023 May; 165(5):1323-1331. PubMed ID: 36920663
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation-based profiling for paediatric CNS tumour diagnosis and treatment: a population-based study.
Pickles JC; Fairchild AR; Stone TJ; Brownlee L; Merve A; Yasin SA; Avery A; Ahmed SW; Ogunbiyi O; Gonzalez Zapata J; Peary AF; Edwards M; Wilkhu L; Dryden C; Ladon D; Kristiansen M; Rowe C; Kurian KM; Nicoll JAR; Mitchell C; Bloom T; Hilton DA; Al-Sarraj S; Doey L; Johns PN; Bridges LR; Chakrabarty A; Ismail A; Rathi N; Syed K; Lammie GA; Limback-Stanic C; Smith C; Torgersen A; Rae F; Hill RM; Clifford SC; Grabovska Y; Williamson D; Clarke M; Jones C; Capper D; Sill M; von Deimling A; Pfister SM; Jones DTW; Hargrave D; Chalker J; Jacques TS
Lancet Child Adolesc Health; 2020 Feb; 4(2):121-130. PubMed ID: 31786093
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic DNA methylome profiling and the WHO 5
Frank S; Hench J
Clin Neuropathol; 2022; 41(4):153-156. PubMed ID: 35670246
[TBL] [Abstract][Full Text] [Related]
15. Molecular Diagnostics in Pediatric Brain Tumors: Impact on Diagnosis and Clinical Decision-Making - A Selected Case Series.
Bächli H; Ecker J; van Tilburg C; Sturm D; Selt F; Sahm F; Koelsche C; Grund K; Sutter C; Pietsch T; Witt H; Herold-Mende C; von Deimling A; Jones D; Pfister S; Witt O; Milde T
Klin Padiatr; 2018 Oct; 230(6):305-313. PubMed ID: 29996150
[TBL] [Abstract][Full Text] [Related]
16. Molecular neuropathology: an essential and evolving toolbox for the diagnosis and clinical management of central nervous system tumors.
Bertero L; Mangherini L; Ricci AA; Cassoni P; Sahm F
Virchows Arch; 2024 Feb; 484(2):181-194. PubMed ID: 37658995
[TBL] [Abstract][Full Text] [Related]
17. Brain Tumor Classification by Methylation Profile.
Park JW; Lee K; Kim EE; Kim SI; Park SH
J Korean Med Sci; 2023 Nov; 38(43):e356. PubMed ID: 37935168
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of histopathological ependymoma variants.
Neumann JE; Spohn M; Obrecht D; Mynarek M; Thomas C; Hasselblatt M; Dorostkar MM; Wefers AK; Frank S; Monoranu CM; Koch A; Witt H; Kool M; Pajtler KW; Rutkowski S; Glatzel M; Schüller U
Acta Neuropathol; 2020 Feb; 139(2):305-318. PubMed ID: 31679042
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal non-meningothelial tumors of the central nervous system: a literature review and diagnostic update of novelties and emerging entities.
Tauziède-Espariat A; Hasty L; Métais A; Varlet P
Acta Neuropathol Commun; 2023 Feb; 11(1):22. PubMed ID: 36737790
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and molecular characterization of a case classified by DNA‑methylation profiling as "CNS embryonal tumor with BRD4-LEUTX fusion".
Lebrun L; Allard-Demoustiez S; Gilis N; Van Campenhout C; Rodesch M; Roman C; Calò P; Lolli V; David P; Fricx C; De Witte O; Escande F; Maurage CA; Salmon I
Acta Neuropathol Commun; 2023 Mar; 11(1):46. PubMed ID: 36934287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
